Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEZEPELUMAB-EKKO Cause Incorrect dose administered by device? 38 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Incorrect dose administered by device have been filed in association with TEZEPELUMAB-EKKO. This represents 0.9% of all adverse event reports for TEZEPELUMAB-EKKO.

38
Reports of Incorrect dose administered by device with TEZEPELUMAB-EKKO
0.9%
of all TEZEPELUMAB-EKKO reports
0
Deaths
1
Hospitalizations

How Dangerous Is Incorrect dose administered by device From TEZEPELUMAB-EKKO?

Of the 38 reports, 1 (2.6%) required hospitalization.

Is Incorrect dose administered by device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEZEPELUMAB-EKKO. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does TEZEPELUMAB-EKKO Cause?

Asthma (630) Dyspnoea (382) Arthralgia (381) Drug ineffective (358) Pneumonia (192) Back pain (184) Cough (182) Rash (177) Pain (148) Product dose omission issue (146)

What Other Drugs Cause Incorrect dose administered by device?

EXENATIDE (3,332) EVOLOCUMAB (2,840) SOMATROPIN (2,486) ALBUTEROL (1,236) ETANERCEPT (1,032) SECUKINUMAB (996) ERENUMAB-AOOE (973) BUDESONIDE\FORMOTEROL (753) INSULIN GLARGINE (753) BUDESONIDE\FORMOTEROL\GLYCOPYRROLATE (674)

Which TEZEPELUMAB-EKKO Alternatives Have Lower Incorrect dose administered by device Risk?

TEZEPELUMAB-EKKO vs THALIDOMIDE TEZEPELUMAB-EKKO vs THALOMID TEZEPELUMAB-EKKO vs THEOPHYLLINE TEZEPELUMAB-EKKO vs THEOPHYLLINE ANHYDROUS TEZEPELUMAB-EKKO vs THIAMINE

Related Pages

TEZEPELUMAB-EKKO Full Profile All Incorrect dose administered by device Reports All Drugs Causing Incorrect dose administered by device TEZEPELUMAB-EKKO Demographics